Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

198
The pathophysiology of pneumonia involves the following steps:
198
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Development and characterization of mouse-adapted recombinant SARS-CoV-2 expressing reporter genes.

Microbiology spectrum·2026
Same author

LRP4 is an entry receptor for multiple encephalitic alphaviruses.

Nature communications·2026
Same author

Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape.

PLoS pathogens·2026
Same author

How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023.

BMJ open·2026
Same author

Respiratory infections due to human common cold coronaviruses, SARS-CoV, MERS-CoV, and SARS-CoV-2: epidemiology, pathogenesis, clinical features, diagnostics, therapeutics, and vaccine landscapes.

The Lancet. Respiratory medicine·2026
Same author

Design of a neutralizing and protective pan-encephalitic alphavirus receptor decoy protein.

Science translational medicine·2026

関連する実験動画

Updated: May 24, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K

肺炎はロングコビッドを誘発する

Alan Sariol1, Stanley Perlman2

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Science (New York, N.Y.)
|March 6, 2025
PubMed
まとめ

マクロファージのペロキシソーム機能障害は,マウスのCOVID-19感染後の肺修復を妨げます. この細胞の欠陥は 病気の後に肺組織を回復する 身体の能力を損ねます

科学分野:

  • 細胞生物学
  • 免疫学
  • 呼吸器医学

背景:

  • COVID-19は肺に重大なダメージを与え,修復メカニズムを損なう可能性があります.
  • マクロファージは組織修復と炎症解消に 重要な役割を果たします
  • ペロキシソームは,酸化ストレス管理を含む様々な代謝プロセスに関与する重要な臓器細胞です.

研究 の 目的:

  • COVID-19後のマクロファージ媒介肺修復におけるペロキシソーム機能障害の役割を調査する.
  • 肺の炎症と再生過程に対するペロキシソーム機能障害の影響を決定する.

主な方法:

  • COVID-19のマウスモデルを使って肺の病理と修復を研究した.
  • マクロファージのペロキシソーム機能障害を誘発または抑制するために遺伝的および薬理学的アプローチを採用した.
  • マクロファージの機能,炎症マーカー,肺の組織再生を分析した.

主要な成果:

  • マクロファージのペロキシソーム機能障害は,COVID-19後のマウスの肺組織修復を著しく阻害した.
  • 機能不全のペロキシソームを持つマウスは,炎症が増加し,肺の再生能力が低下した.
  • ペロキシソーム機能とマクロファージ媒介による修復を結びつける特定の分子経路が特定されました.

さらに関連する動画

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.3K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

6.9K

関連する実験動画

Last Updated: May 24, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.6K
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
08:16

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

7.3K
Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

6.9K

結論:

  • マクロファージの機能不全のペロキシソームは,COVID-19後の肺の回復を制限する重要な要因である.
  • マクロファージのペロキシソーム機能をターゲットにすることは,COVID-19の生存者の肺修復を改善するための新しい治療戦略を表す可能性があります.